key: cord-0708462-8ir8l2tf
authors: Tajstra, Mateusz; Jaroszewicz, Jerzy; Gąsior, Mariusz
title: Acute Coronary Tree Thrombosis After Vaccination for COVID-19
date: 2021-05-10
journal: JACC Cardiovasc Interv
DOI: 10.1016/j.jcin.2021.03.003
sha: 1deabe9605f381e97a9bf092ae1400344e51e288
doc_id: 708462
cord_uid: 8ir8l2tf

nan

Mateusz Tajstra, MD, PHD, a Jerzy Jaroszewicz, MD, PHD, b Mariusz Gąsior, MD, PHD a A lthough the 3 authorized vaccines for COVID-19 appear to be very safe (1) (2) (3) , the vaccines are quite new and dedicated for a new disease, which calls for even very rare events to be shared and discussed broadly with the medical community. Therefore, we would like to present a clinical case of a serious adverse event, possibly linked to 1 of the vaccines for COVID-19. Although it is not possible to ascertain a causal relationship between vaccination and cardiac events, it is important to remember that that the mechanisms of thrombotic events in COVID-19 are still poorly understood (4) . Moreover, the Kounis syndrome-as an adverse event after vaccination-may also be a possible explanation for the presented clinical situation (5). Therefore, the presented case of triple coronary artery thrombosis in a patient recently vaccinated against COVID-19 may provide a causative link between those facts. The study was approved by an appropriate Institutional Review Board.

The authors have reported that they have no relationships relevant to the contents of this paper to disclose.

Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine

An mRNA vaccine against SARS-CoV-2-preliminary report

Information for Healthcare Professionals on COVID-19 Vaccine AstraZeneca

The emerging threat of (micro)thrombosis in COVID-19 and its therapeutic implications